MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM
基于少数民族的社区肿瘤学计划
基本信息
- 批准号:10224106
- 负责人:
- 金额:$ 84.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAddressAdjuvantAdjuvant StudyAdvanced Malignant NeoplasmAftercareAlbert Einstein Cancer CenterAmerican College of Radiology Imaging NetworkAnal carcinomaAreaBiological MarkersBlack raceBreast Cancer DetectionCancer CenterCancer ControlCancer PatientCaringClinicalClinical ResearchCollectionCommittee MembersCommunitiesCommunity Clinical Oncology ProgramCountyCoupledDiagnosisDoctor of PhilosophyEastern Cooperative Oncology GroupEthnic OriginEvaluationFacultyFoundationsFundingGoalsHealth systemHematopoietic NeoplasmsHispanicsHomeInfrastructureInstitutionLanguageLeadershipMalignant NeoplasmsMeasurementMedical centerMedicineMentorsMethodologyMethodsMinorityMinority GroupsMinority ParticipationMissionMorbidity - disease rateNCI-Designated Cancer CenterNeuropathyNew YorkNivolumabOutcomeOutcomes ResearchPatient CarePatientsPilot ProjectsPreventionProtocols documentationRecording of previous eventsResearchResearch PersonnelResourcesRoleSECTM1 geneScienceScreening for cancerSiteSystemTherapeuticTherapeutic TrialsTrainingTraining ProgramsTraining SupportTraining and EducationTranslational ResearchUnderrepresented MinorityUnited StatesUrban Communityanticancer researchbasebiomarker validationblack womencancer carecancer clinical trialcancer health disparitycancer imagingcancer preventioncancer therapycare deliverycareercollegeexperiencefederal poverty levelfinancial toxicityhealth care deliveryhealth related quality of lifeinnovationinstitutional capacitymalignant breast neoplasmmemberminority subjectsmortalitynoveloncology programpatient engagementpopulation basedpostgraduate educationprecision medicineprogramsprospectivescreeningsuccesstaxanetreatment trialtrial designunderserved communityunderserved minority
项目摘要
The overall goals of the Montefiore-Einstein minority-based NCORP community site are to advance the
diagnosis, prevention, and management of early and advanced cancer by participating in NCORP
trials as a minority/underserved community site, and contributing scientifically and administratively to the
NCORP research bases. This will be accomplished by leveraging the strengths of the Montefiore Health
System (MHS), including Montefiore Medical Center (MMC), which brings strengths in integrated patient
care and innovative health care delivery systems in an academic medical center serving a largely
minority population, and the Albert Einstein College of Medicine and Cancer Center (Einstein), which
brings strength in training and education, and in baslc, translational, and clinical research through its NCI-
designated cancer center. The MMC-Einstein program also brings critical leadership to the NCORP
Research Bases, including ECOG-ACRIN, Alliance, and NRG, including leadership roles at the level of the
group chair's office, scientific committee chair (or co-chair), and protocol chair (or co-chair). Our plans
build upon our long-standing involvement in all aspects of cancer research as a main member of
ECOG for 45 years and an NCI-designated cancer center for 48 years, and a strong history of minority
accrual to cancer treatment trials (about 65%of all patients). MMC serves the Bronx, an urban community of
1.47 million residents, of whom 89% are minorities and 29% live below the federal poverty level. In the
prior funding period we had a strong track record scientific contributions to the NCORP research bases, and
met our accrual targets with exceptionally strong minority participation. In the next funding period, we will
continue our strong leadership in cancer therapeutics (EA2165), expand the spectrum of our activities to
include new programs in cancer imaging and screening (TMIST), cancer control/prevention (EAZ171), and
cancer care delivery research (CCDR). The MMC-Einstein NCORP program is led by faculty with
experience in cancer therapeutics and biomarker research (J. Sparano, MD), precision medicine and
immunoncology (B. Halmos, MD), and CCDR and cancer prevention/control (B. Rapkin, PhD), and is
supported by a cadre of other investigators with a broad range of expertise, some of whom benefited from NCI-
funded K12 training program in clinical cancer research.
以 Montefiore-Einstein 少数族裔为基础的 NCORP 社区网站的总体目标是推动
通过参与 NCORP 来诊断、预防和管理早期和晚期癌症
作为少数群体/服务不足的社区站点进行试验,并在科学和行政上为
NCORP 研究基地。这将通过利用 Montefiore Health 的优势来实现
系统 (MHS),包括 Montefiore 医疗中心 (MMC),它带来了综合患者的优势
学术医疗中心的护理和创新医疗保健服务系统,主要服务于
少数族裔人口,以及阿尔伯特·爱因斯坦医学和癌症中心(爱因斯坦)学院,
通过其 NCI- 在培训和教育以及 baslc、转化和临床研究方面带来实力
指定癌症中心。 MMC-爱因斯坦项目还为 NCORP 带来了关键的领导力
研究基地,包括 ECOG-ACRIN、Alliance 和 NRG,包括在
小组主席办公室、科学委员会主席(或联合主席)和礼宾主席(或联合主席)。我们的计划
以我们作为主要成员长期参与癌症研究的各个方面为基础
ECOG 已有 45 年历史,NCI 指定癌症中心已有 48 年历史,并且拥有悠久的少数民族历史
癌症治疗试验的累积(约占所有患者的 65%)。 MMC 为布朗克斯 (Bronx) 提供服务,这是一个城市社区
147 万居民,其中 89% 是少数族裔,29% 生活在联邦贫困线以下。在
在之前的资助期间,我们对 NCORP 研究基地做出了良好的科学贡献,并且
通过异常强烈的少数族裔参与,实现了我们的权责发生制目标。在下一个资助期内,我们将
继续我们在癌症治疗领域的强大领导地位 (EA2165),扩大我们的活动范围
包括癌症成像和筛查 (TMIST)、癌症控制/预防 (EAZ171) 和
癌症护理提供研究(CCDR)。 MMC-Einstein NCORP 项目由具有以下资格的教师领导:
在癌症治疗和生物标志物研究(J. Sparano,医学博士)、精准医学和
免疫肿瘤学(B. Halmos,医学博士),以及 CCDR 和癌症预防/控制(B. Rapkin,博士),并且
得到了一批具有广泛专业知识的其他研究人员的支持,其中一些人受益于 NCI-
资助临床癌症研究的 K12 培训计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Benjamin Adam Gartrell其他文献
Benjamin Adam Gartrell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Benjamin Adam Gartrell', 18)}}的其他基金
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Vaccinating at Mucosal Surfaces with Nanoparticle-conjugated Antigen and Adjuvant
使用纳米颗粒结合的抗原和佐剂在粘膜表面进行疫苗接种
- 批准号:
10587388 - 财政年份:2023
- 资助金额:
$ 84.02万 - 项目类别:
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
因果关系:增强对整个生命周期肉瘤幸存者的理解的队列
- 批准号:
10900883 - 财政年份:2021
- 资助金额:
$ 84.02万 - 项目类别:
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
因果关系:增强对整个生命周期肉瘤幸存者的理解的队列
- 批准号:
10212723 - 财政年份:2021
- 资助金额:
$ 84.02万 - 项目类别:
Novel predictors of survival among breast cancer patients with/without HIV in South Africa
南非感染/未感染艾滋病毒的乳腺癌患者生存的新预测因素
- 批准号:
9982617 - 财政年份:2020
- 资助金额:
$ 84.02万 - 项目类别:
Novel predictors of survival among breast cancer patients with/without HIV in South Africa
南非感染/未感染艾滋病毒的乳腺癌患者生存的新预测因素
- 批准号:
10615640 - 财政年份:2020
- 资助金额:
$ 84.02万 - 项目类别: